Analystreport

Prevail Therapeutics Inc. (NASDAQ: PRVL) had its "buy" rating re-affirmed by analysts at Cowen Inc.

Prevail Therapeutics Inc.  (PRVL) 
Last prevail therapeutics inc. earnings: 11/12 09:30 am Check Earnings Report